Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Natural and Engineered Cytokines as Cancer Therapeutics.

Created on 10 Jul 2026

Authors

Pilar O'Neal, Sonya Kumar Bharathkar, Amelia C McCue, Jamie B Spangler

Published in

Annual review of cancer biology. Volume 10. Pages 39-60. Epub Oct 07, 2025.

Abstract

Cytokines represent a diverse group of soluble proteins that play crucial roles in mediating cellular communication in order to regulate cell fate, particularly in the context of the immune system. Because of their critical roles in controlling cell differentiation, proliferation, migration, activation, and survival, cytokines are heavily implicated in the development and progression, as well as in the prevention and clearance, of cancer. Using both native cytokines and engineered versions thereof, ongoing research in the cancer field endeavors to harness the antitumor activities of cytokines to develop targeted immunotherapies. This review surveys the biology of cytokines and their use in cancer treatment, covering several categories of cytokines, including interleukins, interferons, chemokines, growth factors, and hormones. Preclinical and clinical efforts with natural and engineered cytokines along with efforts to combine these molecules with other anticancer modalities are discussed, highlighting both the triumphs and challenges for these essential proteins in oncology applications.

PMID:
42428769
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement